116 related articles for article (PubMed ID: 6274454)
1. Serum factors inhibiting E-rosette formation in patients with lung malignancies.
Saiz-Garcia F; Rodriguez-Valverde V
Bull Cancer; 1981; 68(4):346-9. PubMed ID: 6274454
[No Abstract] [Full Text] [Related]
2. [Immunological monitoring of patients with carcinoma of the lung. Study method and preliminary research].
Banna P; Stivala F; Murabito R; Cordopatri F; Saggio A; Mosca F; Cinà C
Chir Ital; 1979 Dec; 31(6):1297-1313. PubMed ID: 233422
[TBL] [Abstract][Full Text] [Related]
3. E rosettes in the uranium miners with lung cancer.
Kudrna K; Andrlíková J; Smíd A; Stipl Z
Czech Med; 1979; 2(3):141-7. PubMed ID: 231508
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of antibody synthesis and expression of T-cell membrane markers by serum factors of patients with small cell carcinoma of the lung.
Manke HG; Aulenbacher P; Rüster S; Drings P
Anticancer Res; 1986; 6(4):869-73. PubMed ID: 3019227
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte subpopulation in primary lung cancer.
Alsabti EA; Safo MH; Shaheen A
Oncology; 1979; 36(4):176-9. PubMed ID: 224357
[TBL] [Abstract][Full Text] [Related]
6. [Immunological status in small cell and squamous cell lung cancer].
Janicka G; Przylipiak M; Chyczewska E; Kowal E
Pol Tyg Lek; 1983 Aug; 38(32):985-8. PubMed ID: 6320142
[No Abstract] [Full Text] [Related]
7. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
[No Abstract] [Full Text] [Related]
8. Alveolar cell carcinoma-like antigen and antibodies in patients with alveolar cell carcinoma and other cancers.
Mohr AJ; Nordquist RE; Rhoades ER; Coalson RE; Coalson JJ
Cancer Res; 1974 Aug; 34(8):1904-7. PubMed ID: 4366936
[No Abstract] [Full Text] [Related]
9. Skin test in bronchogenic carcinoma. I. Correlation of the immunological status and the extent of the disease.
Takita H; Brugarolas A
J Surg Oncol; 1973; 5(4):315-8. PubMed ID: 4355620
[No Abstract] [Full Text] [Related]
10. Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin.
Han T; Takita H
Cancer; 1972 Sep; 30(3):616-20. PubMed ID: 4342406
[No Abstract] [Full Text] [Related]
11. [Evaluation of the immunologic system in patients with small cell and squamous cell lung cancer during the early stage of treatment].
Janicka G; Chyczewska E; Przylipiak M; Kowal E
Pol Tyg Lek; 1985 Aug; 40(34):963-6. PubMed ID: 2999734
[No Abstract] [Full Text] [Related]
12. Detection of circulating lung tumor antigen-sensitive T lymphocytes in the early stages of lung cancer.
Ramey WG; Hashim GA; Munther AS; Swistel AJ; Burrows WB; Fitzpatrick HF
Surgery; 1980 Aug; 88(2):202-7. PubMed ID: 6967233
[No Abstract] [Full Text] [Related]
13. [Activated cells in the peripheral blood in lung cancer].
Qian L
Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):18-21, 62. PubMed ID: 2848634
[No Abstract] [Full Text] [Related]
14. Monoclonal antibodies specific for two different histological types of human lung carcinoma.
Saji S; Zylstra S; Schepart BS; Ghosh SK; Jou YH; Takita H; Bankert RB
Hybridoma; 1984; 3(2):119-29. PubMed ID: 6090307
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated immunoglobulins in pulmonary carcinoma.
Gerstl B; Eng LF; Bigbee JW
Cancer Res; 1977 Dec; 37(12):4449-55. PubMed ID: 200349
[TBL] [Abstract][Full Text] [Related]
16. The detection of quantitative serum p53 protein in lung cancer.
Sen E; Gönüllü U; Akar N
Tuberk Toraks; 2005; 53(3):231-7. PubMed ID: 16258881
[TBL] [Abstract][Full Text] [Related]
17. [Serum concentration of C3 in primary lung cancer patients].
Bariffi F; Marsico SA; Vigorito C; Alfani G; Donato Di Paola RM
Arch Monaldi; 1980; 35(4):169-74. PubMed ID: 6282231
[No Abstract] [Full Text] [Related]
18. Peripheral blood lymphocytes and their subpopulations in lung carcinoma.
Zółtowska A; Skokowski J; Mlekodaj S; Boj E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):649-53. PubMed ID: 6970027
[TBL] [Abstract][Full Text] [Related]
19. Depression of T lymphocyte response by non-T suppressor cells in lung cancer patients: a possible prognostic value of suppressor-cell activity.
Han T; Takita H
Cancer; 1979 Dec; 44(6):2090-8. PubMed ID: 228835
[No Abstract] [Full Text] [Related]
20. [Tumour-specific antibodies in the regional lymph nodes of patients with lung cancer (author's transl)].
Matsubara Y; Funatsu T; Hatakenaka R; Kuwabara M; Taki T; Miyamoto Y; Kosaba S; Ninomiya K; Ikeda S
Prax Klin Pneumol; 1980 Sep; 34(9):524-32. PubMed ID: 6256724
[No Abstract] [Full Text] [Related]
[Next] [New Search]
